Literature DB >> 24270739

Cyclin D1 splice site variant triggers chromosomal aberrations in healthy humans.

K Hemminki1, L Musak2, V Vymetalkova3, Z Smerhovsky4, E Halasova5, O Osina2, L Letkova6, A Försti1, L Vodickova3, J Buchancova7, P Vodicka3.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24270739     DOI： 10.1038/leu.2013.353

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

Review 1.  Cyclin D as a therapeutic target in cancer.

Authors:  Elizabeth A Musgrove; C Elizabeth Caldon; Jane Barraclough; Andrew Stone; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

2.  Chromosomal damage among medical staff occupationally exposed to volatile anesthetics, antineoplastic drugs, and formaldehyde.

Authors:  Ludovit Musak; Zdenek Smerhovsky; Erika Halasova; Oto Osina; Lucia Letkova; Ludmila Vodickova; Veronika Polakova; Janka Buchancova; Kari Hemminki; Pavel Vodicka
Journal:  Scand J Work Environ Health       Date:  2013-03-22       Impact factor: 5.024

3.  Chromosomal damage in peripheral blood lymphocytes of newly diagnosed cancer patients and healthy controls.

Authors:  Pavel Vodicka; Zdenka Polivkova; Sylvie Sytarova; Hana Demova; Marie Kucerova; Ludmila Vodickova; Veronika Polakova; Alessio Naccarati; Zdenek Smerhovsky; Miloslav Ambrus; Marie Cerna; Kari Hemminki
Journal:  Carcinogenesis       Date:  2010-03-09       Impact factor: 4.944

4.  A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.

Authors:  Siwanon Jirawatnotai; Yiduo Hu; Wojciech Michowski; Joshua E Elias; Lisa Becks; Frederic Bienvenu; Agnieszka Zagozdzon; Tapasree Goswami; Yaoyu E Wang; Alan B Clark; Thomas A Kunkel; Tanja van Harn; Bing Xia; Mick Correll; John Quackenbush; David M Livingston; Steven P Gygi; Piotr Sicinski
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

5.  IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety.

Authors:  R J Albertini; D Anderson; G R Douglas; L Hagmar; K Hemminki; F Merlo; A T Natarajan; H Norppa; D E Shuker; R Tice; M D Waters; A Aitio
Journal:  Mutat Res       Date:  2000-08       Impact factor: 2.433

Review 6.  Mechanisms that promote and suppress chromosomal translocations in lymphocytes.

Authors:  Monica Gostissa; Frederick W Alt; Roberto Chiarle
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

Review 7.  The genetic architecture of multiple myeloma.

Authors:  Gareth J Morgan; Brian A Walker; Faith E Davies
Journal:  Nat Rev Cancer       Date:  2012-04-12       Impact factor: 60.716

Review 8.  The impact of translocations and gene fusions on cancer causation.

Authors:  Felix Mitelman; Bertil Johansson; Fredrik Mertens
Journal:  Nat Rev Cancer       Date:  2007-03-15       Impact factor: 60.716

9.  Massive genomic rearrangement acquired in a single catastrophic event during cancer development.

Authors:  Philip J Stephens; Chris D Greenman; Beiyuan Fu; Fengtang Yang; Graham R Bignell; Laura J Mudie; Erin D Pleasance; King Wai Lau; David Beare; Lucy A Stebbings; Stuart McLaren; Meng-Lay Lin; David J McBride; Ignacio Varela; Serena Nik-Zainal; Catherine Leroy; Mingming Jia; Andrew Menzies; Adam P Butler; Jon W Teague; Michael A Quail; John Burton; Harold Swerdlow; Nigel P Carter; Laura A Morsberger; Christine Iacobuzio-Donahue; George A Follows; Anthony R Green; Adrienne M Flanagan; Michael R Stratton; P Andrew Futreal; Peter J Campbell
Journal:  Cell       Date:  2011-01-07       Impact factor: 41.582

10.  The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.

Authors:  Niels Weinhold; David C Johnson; Daniel Chubb; Bowang Chen; Asta Försti; Fay J Hosking; Peter Broderick; Yussanne P Ma; Sara E Dobbins; Dirk Hose; Brian A Walker; Faith E Davies; Martin F Kaiser; Ni L Li; Walter A Gregory; Graham H Jackson; Mathias Witzens-Harig; Kai Neben; Per Hoffmann; Markus M Nöthen; Thomas W Mühleisen; Lewin Eisele; Fiona M Ross; Anna Jauch; Hartmut Goldschmidt; Richard S Houlston; Gareth J Morgan; Kari Hemminki
Journal:  Nat Genet       Date:  2013-03-17       Impact factor: 38.330
View more
  2 in total

1.  Polymorphisms of GSTM1, GSTT1, GSTP1 genes and chromosomal aberrations in lung cancer patients.

Authors:  Varvara I Minina; Olga A Soboleva; Andrey N Glushkov; Elena N Voronina; Ekaterina A Sokolova; Marina L Bakanova; Yana A Savchenko; Anastasia V Ryzhkova; Ruslan A Titov; Vladimir G Druzhinin; Maxim Yu Sinitsky; Maxim A Asanov
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-02       Impact factor: 4.553

2.  Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma.

Authors:  N Weinhold; A Försti; M I da Silva Filho; J Nickel; C Campo; P Hoffmann; M M Nöthen; D Hose; H Goldschmidt; A Jauch; C Langer; U Hegenbart; S O Schönland; K Hemminki
Journal:  Leukemia       Date:  2014-07-03       Impact factor: 11.528
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.